Michael Doluisio > Dechert LLP > Philadelphia, United States > Lawyer Profile

The trial, investigations and securities practice at Dechert LLP has a deep bench of partners who represent a diverse range of clients, among them leading mutual funds and corporate issuers of securities. Practice head David Kistenbroker and key partner Joni Jacobsen, who work out of both the Chicago and New York offices, are highly praised by peers. They are currently handling a class action against Antares Pharma, Inc. that alleges the company provided insufficient information to the FDA in support of testosterone replacement therapy Xyosted and subsequently overstated the drug’s approval prospects, rendering public statements false and misleading. Regulatory enforcement specialist Michael Doluisio in Philadelphia and New York litigation partner Andrew Levander are acting for AmerisourceBergen Corp. in a shareholder derivative suit filed in Delaware Chancery Court accusing the company breaching its fiduciary duties by failing to oversee compliance with federal regulations concerning distribution of controlled substances and their contributing to the opioid epidemic. Matthew Larrabee, Andrew Levander and Linda Goldstein are the key practitioners in New York. In San Francisco, corporate governance litigation partner Richard Horvath and securities and antitrust partner Josh Hess are the main contacts.